← Browse by Condition
Medical Condition
relapsed adult aml
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT06022003 Phase 2
Recruiting
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
Enrollment
33 pts
Location
France
Sponsor
French Innovative Leukemia Org...
NCT06649227 Phase 1
Recruiting
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
Enrollment
5 pts
Location
France
Sponsor
University Hospital, Lille